¼¼°èÀÇ ³­Ã» Áúȯ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Hearing Loss Disease Treatment Global Market Report 2025
»óǰÄÚµå : 1760547
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,233,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,010,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,786,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

³­Ã» Áúȯ Ä¡·á ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 6.6%·Î 177¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ȯ°æ ¼ÒÀ½ ¹× Á÷¾÷ ¼ÒÀ½ ³ëÃâ Áõ°¡, ¿ø°Ý û·ÂÇРäÅà Ȯ´ë, ÃæÀü½Ä º¸Ã»±â ¹× AI ±â¹Ý º¸Ã»±â ¼ö¿ä Áõ°¡, ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÇコÄɾî ÅõÀÚ Áõ°¡, ³­Ã»¿¡ ´ëÇÑ À¯ÀüÀÚ Ä¡·á ¹× Áٱ⼼Æ÷ Ä¡·á ¿¬±¸ È®´ë µî¿¡ ±âÀÎÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä µ¿ÇâÀ¸·Î´Â AI ±â¹Ý º¸Ã»±â, û·Â ȸº¹À» À§ÇÑ Àç»ýÀÇ·á, ¹«¼± ¹× ºí·çÅõ½º Áö¿ø º¸Ã»±â, ¸ÂÃãÇü º¸Ã»±â¸¦ À§ÇÑ 3D ÇÁ¸°ÆÃ, ¿ø°Ý û·ÂÇÐ ¹× ¿ø°Ý û·Â °ü¸®ÀÇ È®´ë µîÀÌ ÀÖ½À´Ï´Ù.

¼ÒÀ½ °øÇØ¿¡ ´ëÇÑ ³ëÃâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ³­Ã» Áúȯ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀÌ °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ÒÀ½ °øÇØ´Â Àΰ£ÀÇ °Ç°­, ¾ß»ý µ¿¹° ¹× Àü¹ÝÀûÀÎ À£ºù¿¡ ÇØ¸¦ ³¢Ä¥ ¼ö Àִ ȯ°æÀÇ °úµµÇϰųª ÆÄ±«ÀûÀÎ ¼öÁØÀÇ ¼Ò¸®¸¦ ¸»ÇÕ´Ï´Ù. ±³Åë üÁõÀÌ Áõ°¡ÇÏ°í ´õ ¸¹Àº ÀÚµ¿Â÷°¡ ²÷ÀÓ¾ø´Â ¿£Áø ¼Ò¸®¿Í °æÀû ¼Ò¸®¸¦ ³»¸é¼­ µµ½Ã Áö¿ªÀÇ È¯°æ ¼ÒÀ½ ¼öÁØÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ³ôÀº ¼ÒÀ½¿¡ Àå½Ã°£ ³ëÃâµÇ¸é û·Â ¼Õ»óÀ» À¯¹ßÇÒ ¼ö ÀÖÀ¸¸ç, ³­Ã» Áõ°¡ÀÇ ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó º¸Ã»±â ¹× ÀÇ·áÀû °³ÀÔ°ú °°Àº È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, º§±â¿¡¿¡ º»ºÎ¸¦ µÐ À¯·´ ȯ°æÃ»Àº 2022³â 12¿ù¿¡ 8,700¸¸ ¸íÀÌ Á־߰£ 55dB ÀÌ»óÀÇ µµ·Î ¼ÒÀ½¿¡ ³ëÃâµÇ¾î ÀÖÀ¸¸ç, ƯÈ÷ ¾à 5,600¸¸ ¸íÀÌ ¾ß°£ ¼ÒÀ½ÀÇ ¿µÇâÀ» ¹Þ´Â´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌó·³ ¼ÒÀ½ °øÇØ¿¡ ´ëÇÑ ³ëÃâÀÌ Áõ°¡Çϸ鼭 ³­Ã» Áúȯ Ä¡·á ½ÃÀåÀÇ È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

³­Ã» Áúȯ Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº Á¢±Ù¼º, °æÁ¦¼º, ÆíÀǼºÀ» ³ôÀ̱â À§ÇØ OTC(Over-the-Counter) º¸Ã»±â µî ÷´Ü ±â¼úÀ» °³¹ßÇϰí ÀÖÀ¸¸ç, OTC º¸Ã»±â´Â °æµµ¿¡¼­ Áߵ ³­Ã» ȯÀÚ¸¦ À§ÇØ ¼³°èµÈ ºñó¹æ º¸Ã»±âÀÔ´Ï´Ù. ÀÌ º¸Ã»±âµéÀº Áø·á³ª ó¹æÀü, Àü¹®°¡ÀÇ ÇÇÆÃÀÌ ÇÊ¿ä ¾øÀÌ ¼ÒºñÀÚ°¡ Á÷Á¢ ±¸¸ÅÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù, ¹Ì±¹ ÀÇ·á±â±â Á¦Á¶¾÷üÀÎ Eargo´Â Eargo SE¿Í Link¶ó´Â µÎ °¡Áö Çõ½ÅÀûÀÎ OTC º¸Ã»±â¸¦ Ãâ½ÃÇߴµ¥, Eargo SE´Â ¼¿ÇÁ ÇÇÆÃ ±â´É, ÃæÀü½Ä ÆíÀǼº, Æí¾ÈÇÔÀ» Çâ»ó½Ã۱â À§ÇØ Àç¼³°èµÈ À̾îÆÁ, Á¤±³ÇÑ ÄÄÆÐ´Ï¾ð ¾Û, ÄÄÆÑÆ®ÇÑ ÃæÀü ÄÉÀ̽º, °ÅÀÇ ´«¿¡ ¶çÁö ¾Ê´Â Ä¿³ÎÇü µðÀÚÀÎÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ÇÑÆí, LINK´Â ºí·çÅõ½º 5.3 ¿Àµð¿À ½ºÆ®¸®¹ÖÀ» Áö¿øÇÏ´Â ÃÖÃÊÀÇ º¸Ã»±âÀÎ ¼±±¸ÀûÀÎ À̾îÆùÇü µðÀÚÀÎÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. Eargo´Â À̹ø ½ÅÁ¦Ç°À» ÅëÇØ Çö´ë ¼ÒºñÀÚÀÇ ÁøÈ­ÇÏ´Â ´ÏÁî¿Í ÃëÇâ¿¡ ¸ÂÃç »ç¿ëÇϱ⠽±°í °íǰÁúÀÇ Ã»°¢ ¼Ö·ç¼ÇÀ» Á¦°øÇϰڴٴ ¾à¼ÓÀ» ´Ù½Ã ÇÑ ¹ø È®ÀÎÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Hearing loss disease treatment refers to the medical, surgical, or therapeutic interventions used to manage or restore hearing function in individuals with partial or complete hearing impairment. The treatment approach is determined by the cause, type, and severity of the hearing loss. It includes hearing aids, cochlear implants, medications, and surgical procedures.

The primary treatments for hearing loss include hearing aids, cochlear implants, medications, surgery, and other interventions. Hearing aids are small electronic devices designed to amplify sound for individuals with hearing impairment. They consist of a microphone to capture sound, an amplifier to increase its intensity, and a speaker to deliver the amplified sound into the ear. The patient categories include pediatric, adult, and geriatric populations, while the distinct types of hearing loss are sensorineural, conductive, and mixed. Severity levels range from mild to profound hearing loss. Major end-users of these treatments include hospitals, otology clinics, and ambulatory surgical centers.

The hearing loss disease treatment market research report is one of a series of new reports from The Business Research Company that provides hearing loss disease treatment market statistics, including hearing loss disease treatment industry global market size, regional shares, competitors with a hearing loss disease treatment market share, detailed hearing loss disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the hearing loss disease treatment industry. The hearing loss disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hearing loss disease treatment market size has grown strongly in recent years. It will grow from$12.85 billion in 2024 to $13.74 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be attributed to the increasing aging population, a higher prevalence of age-related hearing loss, growing awareness and early diagnosis, government initiatives for hearing care, and the rise in noise pollution and occupational hazards.

The hearing loss disease treatment market size is expected to see strong growth in the next few years. It will grow to$17.76 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth during the forecast period can be attributed to increased exposure to environmental and occupational noise, the growing adoption of teleaudiology, rising demand for rechargeable and AI-powered hearing aids, higher healthcare investments in emerging markets, and expanding research in gene and stem cell therapy for hearing loss. Key trends in the forecast period include AI-powered hearing aids, regenerative medicine for hearing restoration, wireless and Bluetooth-enabled hearing devices, 3D printing for custom hearing aids, and the expansion of teleaudiology and remote hearing care.

The growing exposure to noise pollution is expected to accelerate the growth of the hearing loss treatment market. Noise pollution refers to excessive or disruptive levels of sound in the environment that can harm human health, wildlife, and overall well-being. As traffic congestion increases and more vehicles contribute to constant engine and horn noises, ambient noise levels in urban areas are rising. Prolonged exposure to high noise levels can lead to hearing damage, contributing to the growing incidence of hearing loss. Consequently, the demand for effective treatment options, such as hearing aids and medical interventions, is expected to rise. For example, in December 2022, the European Environment Agency, based in Belgium, reported that 87 million people were exposed to road noise levels of 55 dB or higher during the day-evening-night period, with around 56 million specifically affected by nighttime noise. This increasing exposure to noise pollution is therefore fueling the expansion of the hearing loss treatment market.

Leading companies in the hearing loss treatment market are developing advanced technologies such as over-the-counter (OTC) hearing wellness devices to enhance accessibility, affordability, and convenience. OTC hearing wellness devices are non-prescription hearing aids designed for individuals with mild to moderate hearing loss. These devices can be purchased directly by consumers without the need for a medical exam, prescription, or professional fitting. For example, in January 2024, Eargo Inc., a US-based medical device company, introduced two innovative OTC hearing aids, Eargo SE and LINK. The Eargo SE features a nearly invisible, in-canal design with self-fitting functionality, rechargeable convenience, a redesigned ear tip for improved comfort, a sleek companion app, and a compact charging case. Meanwhile, LINK presents a pioneering earbud-style design, becoming the first hearing aid to support Bluetooth 5.3 audio streaming. With these new products, Eargo reaffirms its commitment to providing accessible, high-quality hearing solutions that meet the evolving needs and preferences of modern consumers.

In April 2022, Autigen, a US-based biotechnology company focused on novel treatments for hearing loss, partnered with Boehringer Ingelheim to develop advanced therapies for individuals with sensorineural hearing conditions. This collaboration aims to create the first pharmacological solution for hearing loss, an area currently lacking approved drug-based treatments. The companies are focusing on developing a small-molecule therapy that can be administered either orally or through injection, providing an alternative to traditional interventions such as hearing aids or cochlear implants. Boehringer Ingelheim, a Germany-based pharmaceutical company with expertise in neurology and regenerative medicine, is working alongside Autigen to bring this groundbreaking treatment to market.

Major players in the hearing loss disease treatment market are Astellas Pharma Inc., Sonova Holding AG, Demant A/S, GN Store Nord A/S, Amplifon SpA, Cochlear Limited, Starkey Hearing Technologies, Widex A/S, Oticon Inc, MED-EL Medical Electronics, Beltone, IntriCon Corporation, Phonak AG, RION Co Ltd, Eargo Inc, Arphi Electronics Pvt Ltd, Zounds Hearing Inc, Sivantos Group, Audina Hearing Instruments, WS Audiology, Sensorion SA, Otonomy Inc, Audifon GmbH & Co KG, Horentek Hearing Diagnostics, Pipeline Therapeutics, Acousia Therapeutics GmbH, ReSound Group, and Natus Medical Incorporated.

North America was the largest region in the hearing loss disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hearing loss disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hearing loss disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hearing loss disease treatment market consists of revenues earned by entities providing services such as audiology and diagnostic services, hearing aid fitting and maintenance, hearing rehabilitation and therapy, and cochlear implant services. The market value includes the value of related goods sold by the service provider or included within the service offering. The hearing loss disease treatment market also includes sales of hearing aids, cochlear implants, bone-anchored hearing aids, middle ear implants, and hearing protection devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hearing Loss Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hearing loss disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for hearing loss disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hearing loss disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Hearing Loss Disease Treatment Market Characteristics

3. Hearing Loss Disease Treatment Market Trends And Strategies

4. Hearing Loss Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hearing Loss Disease Treatment Growth Analysis And Strategic Analysis Framework

6. Hearing Loss Disease Treatment Market Segmentation

7. Hearing Loss Disease Treatment Market Regional And Country Analysis

8. Asia-Pacific Hearing Loss Disease Treatment Market

9. China Hearing Loss Disease Treatment Market

10. India Hearing Loss Disease Treatment Market

11. Japan Hearing Loss Disease Treatment Market

12. Australia Hearing Loss Disease Treatment Market

13. Indonesia Hearing Loss Disease Treatment Market

14. South Korea Hearing Loss Disease Treatment Market

15. Western Europe Hearing Loss Disease Treatment Market

16. UK Hearing Loss Disease Treatment Market

17. Germany Hearing Loss Disease Treatment Market

18. France Hearing Loss Disease Treatment Market

19. Italy Hearing Loss Disease Treatment Market

20. Spain Hearing Loss Disease Treatment Market

21. Eastern Europe Hearing Loss Disease Treatment Market

22. Russia Hearing Loss Disease Treatment Market

23. North America Hearing Loss Disease Treatment Market

24. USA Hearing Loss Disease Treatment Market

25. Canada Hearing Loss Disease Treatment Market

26. South America Hearing Loss Disease Treatment Market

27. Brazil Hearing Loss Disease Treatment Market

28. Middle East Hearing Loss Disease Treatment Market

29. Africa Hearing Loss Disease Treatment Market

30. Hearing Loss Disease Treatment Market Competitive Landscape And Company Profiles

31. Hearing Loss Disease Treatment Market Other Major And Innovative Companies

32. Global Hearing Loss Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hearing Loss Disease Treatment Market

34. Recent Developments In The Hearing Loss Disease Treatment Market

35. Hearing Loss Disease Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â